CellPly Company

Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing the ability to monitor the clinical response to these treatments. Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
Technology: Biotechnology, Health Care, Medical
Industry: Early Drug Development, Preclinical Development
Headquarters: Bologna, Emilia-Romagna, Italy
Founded Date: 2013-01-01
Employees Number: 11-50
Funding Status: Seed
Investors Number: 8
Total Funding: 8136841
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-12-15
Last Funding Type: Venture - Series Unknown

Visit Website
info@cellply.com
http://twitter.com/cellply
Register and Claim Ownership